Substance use & recovery · Understand your experience

Sedative, hypnotic or anxiolytic use disorder

Being worried about a medicine you rely on can feel complicated. You can ask for a review that takes both its benefits and your concerns seriously, without assuming that physical dependence means a use disorder.

Physical dependence and a use disorder are different.
01 / Get a clearer picture

Start with the exact medicine and your experience.

This broad clinical category concerns problematic use of sedative, hypnotic or anxiolytic substances. Different medicines have different risks and treatment considerations. The name alone does not tell you what applies to your prescription.

For benzodiazepines, physical dependence can develop during prescribed use. It is distinct from a use disorder. A clinician should consider benefits, unwanted effects, how the medicine is taken and your wider care.

Based on FDA · ASAM and partner societies

Physical dependence and a use disorder are different.
A visual explanation

A medicine review has room for benefits and concerns.

  • The medicine

    Its name, purpose and prescribed care

  • The benefit

    What it helps you with

  • The concern

    Effects, control, interactions or withdrawal

  • The review

    Individual decisions with a professional

Review areas rather than diagnostic stages. Physical dependence is distinct from a use disorder; this is not a tapering plan. Source: FDA
A closer look

Dependence during treatment does not automatically mean a use disorder.

Physical dependence can develop with prescribed benzodiazepines. A use disorder involves a broader clinical assessment. Tell the clinician which medicine you take and what worries you, including symptoms after a change.

The term sedative covers different medicines. Information about benzodiazepines cannot be assumed to describe every other sedative in the same way.

  • Physical dependence

    Adaptation that may lead to withdrawal when treatment changes.

  • Use-disorder assessment

    A wider evaluation of the use pattern, control and consequences.

Related but distinct concepts; neither card diagnoses your situation.

Based on FDA · MHRA

A closer look

Needing a safe plan does not define your diagnosis.

Physical dependence describes adaptation to a medicine, with possible withdrawal when it is reduced or stopped. A use disorder concerns a problematic pattern and its effects. They can overlap, but one does not establish the other. Benzodiazepine guidance explicitly asks clinicians to keep this distinction clear.

Based on FDA · ASAM and partner societies

02 / Make sense of what has changed

Take concerns to a review, rather than labelling yourself.

These examples are reasons to discuss care. They are not diagnostic criteria to apply to someone else's medicine use.

Medicine benefits

Taking more than prescribed or finding use difficult to control.

Unwanted effects

Medicine use getting in the way of things you need or want to do.

Withdrawal worries

Unwanted effects or concerns about combining medicines, alcohol or other substances.

Safe review

Withdrawal concerns or feeling unsure how to approach a change safely.

Based on FDA · ASAM and partner societies · NIDA Data Share · NIH

03 / Put your experience into context

Your prescription and treatment history matter.

Bring the medicine names, how you take them, why they were prescribed and any changes or missed doses. A professional can consider physical dependence, a possible use disorder and other explanations separately.

Screening for nonmedical use cannot determine a taper or establish the safety of a medication change. Evidence about benzodiazepines should not be applied automatically to every sedative or sleeping medicine.

Based on FDA · ASAM and partner societies · NIDA Data Share · NIH

Your experience, in three prompts
  1. 1
    The benefit

    What does the medicine help you with?

  2. 2
    The concern

    What effects, use changes or withdrawal worries matter?

  3. 3
    The review

    What would safe, individual follow-up involve?

Make a few notes
04 / Explore your support options

Make medicine decisions with a professional.

You and your clinician can discuss what fits your needs, preferences and health.

Based on FDA · ASAM and partner societies · NHS

A medication review

A review can weigh the benefits and risks of continuing a medicine and whether any change is appropriate. If a benzodiazepine reduction is agreed, clinical guidance calls for an individual plan and monitoring. This page does not provide dose or timing instructions.

Support around the concern

Care can also address the anxiety, insomnia or other condition for which treatment began. If a use disorder is identified, ask about specialist support that works alongside your wider health care.

Understand your options

Discuss changes with the prescriber first.

Abruptly stopping benzodiazepines or reducing too quickly can cause serious withdrawal. Get individual medical advice rather than following a general taper schedule.

Ask how the original reason for treatment, other medicines and ongoing symptoms will be reviewed. A plan should include who to contact if symptoms become difficult.

Based on FDA · MHRA

05 / Choose your next step

A little clarity. A place to start.

Explore a tool, prepare a conversation or find someone to talk to. Choose what feels useful to you.

Questionnaires you might hear about

TAPS can open a conversation about nonmedical medicine use. It is not a benzodiazepine-withdrawal tool, a tapering calculator or a substitute for reviewing prescribed treatment.

TAPS

A starting conversation across substance categories.

Tobacco, Alcohol, Prescription Medication and Other Substance Use Tool

An adult primary-care tool with an initial screen about the past year and substance-specific follow-up about the past three months. Prescribed use and nonmedical use need different context.

What it can and cannot tell you

The exact form, digital-use permission and follow-up branches have not cleared release here. Its substance-specific results do not form one addiction score or establish a diagnosis.

Official measure information

Based on NIDA Data Share · NIH

These measures are explained here, rather than administered. You can ask for support without a score or a diagnosis, and choose how much to share in your first conversation.

Something you can use today

Practical guideYour words

Prepare for a conversation

A few prompts to help you explain what you have noticed and what you would like help with.

  • A simple notes builder
  • Copy your notes to keep
  • No account needed

You decide how much to write and share.

Find your words
Support directorySomeone beside you

Find your next kind of support

Explore where to begin with everyday support, professional help or an urgent conversation.

  • Ways to ask for help
  • Country-specific crisis contacts
  • Support at your own pace

If you need urgent help, go straight to support.

Find support
You can start right here

Your first sentence does not need to be perfect.

Explain both the benefit and the concern, and ask how to proceed safely. Mention other medicines, alcohol or opioids. Do not abruptly stop or change treatment while waiting for a questionnaire result.

Based on FDA · ASAM and partner societies

“I would like to review this medicine, including what it helps with, my concerns and how any change could be managed safely.”
Make it sound like you
Things you may be wondering

Your questions, with room for nuance.

You can read just the answer you need.

Can an online test choose a safe stopping schedule?

No. A questionnaire cannot choose a taper or judge interactions. A qualified clinician needs your medicine and health context.

Based on FDA · MHRA

Where this information comes from.

Use this hub to learn and prepare questions. It does not diagnose you or recommend a personal treatment plan. By Selfmora editorial; sources checked . Updated .

Additional explanations and examples: sources consulted . Examples illustrate ideas; they do not assess your personal health. Your questions

Our editorial approach